Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2637-2641
Published online before print November 3, 2005, doi: 10.1161/01.STR.0000189721.31432.26
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/12/2637    most recent
01.STR.0000189721.31432.26v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Oijen, M.
Right arrow Articles by Breteler, M. M.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Oijen, M.
Right arrow Articles by Breteler, M. M.B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Alzheimer's Disease
Related Collections
Right arrow Coagulation
Right arrow Fibrinogen/fibrin
Right arrow Epidemiology

(Stroke. 2005;36:2637.)
© 2005 American Heart Association, Inc.


Original Contributions

Fibrinogen Is Associated With an Increased Risk of Alzheimer Disease and Vascular Dementia

Marieke van Oijen, MD; Jacqueline C. Witteman, PhD; Albert Hofman, MD, PhD; Peter J. Koudstaal, MD, PhD Monique M.B. Breteler, MD, PhD

From the Departments of Epidemiology and Biostatistics (M.v.O., J.C.W., A.H., M.M.B.B.) and Neurology (M.v.O., P.J.K.), Erasmus Medical Center, Rotterdam, the Netherlands.

Correspondence to Monique M.B. Breteler, MD, PhD, Department of Epidemiology and Biostatistics, Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, the Netherlands. E-mail m.breteler{at}erasmusmc.nl

Background and Purpose— Vascular and inflammatory factors may play an important role in the pathogenesis of dementia. Studies reported an association between plasma levels of inflammation markers and the risk of dementia. Both fibrinogen and C-reactive protein are considered inflammatory markers. Fibrinogen also has important hemostatic properties. We investigated the association of fibrinogen and C-reactive protein with dementia.

Methods— The study was based on the prospective population-based Rotterdam Study. Fibrinogen was measured in a random sample of 2835 persons. High-sensitivity C-reactive protein was measured in the total cohort of 6713 persons. We identified 395 incident dementia cases during follow-up (mean, 5.7 years). We estimated the associations of fibrinogen and C-reactive protein with dementia using Cox proportional hazard models.

Results— Persons with higher levels of fibrinogen had an increased risk of dementia. The hazard ratio for dementia per SD increase of fibrinogen was 1.26 (95% CI, 1.11 to 1.44), adjusted for age and gender, and 1.30 (95% CI, 1.13 to 1.50) after additional adjustment for cardiovascular factors and stroke. For Alzheimer disease, the adjusted hazard ratio was 1.25 (95% CI, 1.04 to 1.49), and for vascular dementia it was 1.76 (95% CI, 1.34 to 2.30). High levels of C-reactive protein were not associated with an increased risk of dementia.

Conclusions— High fibrinogen levels were associated with an increased risk of both Alzheimer disease and vascular dementia, but levels of C-reactive protein were not. This suggests that the increased risk of dementia associated with fibrinogen is because of the hemostatic rather than the inflammatory properties of fibrinogen.


Key Words: fibrinogen • C-reactive protein • dementia • Alzheimer disease • risk




This article has been cited by other articles:


Home page
StrokeHome page
M. Di Napoli and P. Singh
Is Plasma Fibrinogen Useful in Evaluating Ischemic Stroke Patients?: Why, How, and When
Stroke, May 1, 2009; 40(5): 1549 - 1552.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M van Oijen, E Y L Cheung, C E M Geluk, A Hofman, P J Koudstaal, M M B Breteler, and M P de Maat
Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study
J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 799 - 803.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Sato, H. Iso, H. Noda, A. Kitamura, H. Imano, M. Kiyama, T. Ohira, T. Okada, M. Yao, T. Tanigawa, et al.
Plasma Fibrinogen Concentrations and Risk of Stroke and Its Subtypes Among Japanese Men and Women
Stroke, October 1, 2006; 37(10): 2488 - 2492.
[Abstract] [Full Text] [PDF]